Does an anhydrous (waterless) facial oil serum require a microbiological challenge test (ISO 11930)?

No. A facial serum formulated purely with botanical oils, dry squalane esters, and tocopherol (vitamin E) contains zero water. Because microorganisms cannot replicate in the absence of free water, the formula is categorized as low microbiological risk under ISO 29621 and is exempt from challenge testing. However, accelerated physicochemical stability testing (rancidity and peroxide value monitoring) remains strictly mandatory.

Can I claim "preservative-free" on an aqueous face serum?

Under European Commission Regulation (EU) No 655/2013 and industry claim guidelines, "free-from" claims are tightly restricted. A "preservative-free" claim is only legally permissible if the formulation contains zero substances listed in Annex V of the Cosmetic Regulation and contains no multifunctional ingredients providing unlisted antimicrobial action. If hurdle technologies or non-Annex V glycols (like glyceryl caprylate) are utilized, claiming "preservative-free" is classified as misleading advertising.

How do I substantiate an "anti-aging" or "wrinkle reduction" claim in the PIF?

To display explicit efficacy claims (such as "reduces wrinkle depth by 20%"), you must archive objective evidence in Section 4 of the PIF. Acceptable proof includes randomized clinical instrumental trials (e.g., 3D skin profilometry or cutometer elasticity testing) or controlled dermatological in-use trials on human volunteers conducted by an accredited third-party testing facility.

Facial Care PIF: Validate Your Face Care Products

Facial Care PIF: Regulation and Validation for Face Care Cosmetics

Facial skincare products (hydrating day creams, high-potency serums, delicate eye contour treatments, exfoliating scrubs, and facial masks) represent the cornerstone of the premium cosmetic industry. However, evaluating the toxicological safety of facial cosmetics is exceptionally demanding due to the biological sensitivity of facial skin and the direct vicinity of delicate mucous membranes (ocular conjunctiva and oral mucosa). To legally market your facial skincare range in Europe, you must compile a Product Information File (PIF) (PIF) compliant with Regolamento (CE) N. 1223/2009. Here is our dedicated regulatory compliance guide.

💡 Launching a facial skincare range, serum, or eye cream? Estimate your regulatory compliance budget in 2 minutes with our online configurator.

Launch the Configurator →

Toxicological Valutazione della Sicurezza Specifics for Facial Skincare

During the drafting of the Cosmetic Product Safety Report (CPSR (Cosmetic Product Safety Report)) for your facial care range, our qualified Valutatore della Sicurezza Cosmetica / Tossicologo focuses on several critical safety criteria:

Ocular and dermal tolerance: facial skin is thin, delicate, and highly reactive. Human dermatological patch tests and in vitro ocular tolerance assays (such as the Neutral Red Release assay, BCOP, or HET-CAM) are indispensable, particularly for eye contour treatments, micellar waters, and makeup removers.
Concentration limits on restricted actives: numerous popular facial actives are subject to strict regulatory ceilings. For instance, salicylic acid is limited to a maximum of 2.0% in facial cosmetics under Annex III, and retinol (vitamin A) is restricted to a maximum concentration of 0.3% in leave-on facial products following European Commission updates.
Phototoxicity and photosensitization: daytime facial products are exposed to direct sunlight. The inclusion of potentially phototoxic botanicals (such as cold-pressed citrus essential oils containing furocoumarines/bergapten) is rigorously evaluated to prevent severe post-exposure dermal reactions.

The facial care PIF compiles all formulation data, manufacturing batch records, and safety test reports. To understand the foundational administrative framework of your regulatory file, consult our primary guide on the PIF cosmetici.

🔬 Insights from our Valutatore della Sicurezza Cosmetica

"The SCCS calculates daily adult facial cosmetic exposure at 1.54 grams per day for leave-on face cream. While this mass is smaller than full-body lotion application, transdermal penetration is substantially higher due to the thinness of the facial stratum corneum (especially around the eyes, where skin is four times thinner than on the body). The selection of preservatives and fragrance compounds is critical: formulators must maintain a Margin of Safety (MoS) well above 100 while actively eliminating sensitizing substances."

Structure of the PIF for Facial Skincare Lines

To validate your facial skincare collection, the compliance archive held at your European business premises must incorporate:

Complete qualitative and quantitative formulation using standardized INCI nomenclature.
Cosmetic Product Safety Report (CPSR (Cosmetic Product Safety Report) Parts A and B) drafted and formally signed by our qualified Valutatore della Sicurezza.
Formal Buone Pratiche di Fabbricazione (GMP (ISO 22716)) declaration confirming manufacturing facility compliance with ISO 22716.
Laboratory reports detailing physicochemical stability, packaging compatibility, and ISO 11930 challenge testing.
Official CPNP notification receipt.

Our regulatory team provides turnkey support for your cosmetic projects. Review our service tiers and pricing in our dedicated PIF services guide.

⚠️ 3 Frequent Regulatory Pitfalls in Facial Cosmetics

Omitting mandatory warning labels for salicylic acid: any facial cosmetic utilizing salicylic acid for exfoliating or clarifying purposes must state "not to be used for children under 3 years of age" on primary and secondary labeling.
Making medicinal therapeutic acne claims: claiming that a cosmetic cream "cures acne", "eradicates pimples", or "heals infected comedones" reclassifies the product as an illegal unregistered drug. Formulators must restrict wording to cosmetic claims ("purifies", "blemish-prone skin").
Omitting ocular tolerance testing on facial cleansers: failing to provide in vitro ocular tolerance assay data for face and eye makeup removers constitutes a major deficiency during health authority audits.

Active clinical ingredients

Cross-Regulatory Links with Related Skincare Ranges

Your facial skincare portfolio integrates within an overarching regulatory strategy. Depending on your catalog extensions, explore our related technical guides:

For hair and scalp cosmetics, consult our guide on the hair care and beard PIF.
For body lotions and body hygiene products, see our guide on the body care and hygiene PIF.
For color cosmetics and shaving preparations, read our guide on makeup cosmetic regulation.

Frequently Asked Questions About Facial Care PIF

Does an anhydrous (waterless) facial oil serum require a microbiological challenge test (ISO 11930)?: No. A facial serum formulated purely with botanical oils, dry squalane esters, and tocopherol (vitamin E) contains zero water. Because microorganisms cannot replicate in the absence of free water, the formula is categorized as low microbiological risk under ISO 29621 and is exempt from challenge testing. However, accelerated physicochemical stability testing (rancidity and peroxide value monitoring) remains strictly mandatory.
Can I claim "preservative-free" on an aqueous face serum?: Under European Commission Regulation (EU) No 655/2013 and industry claim guidelines, "free-from" claims are tightly restricted. A "preservative-free" claim is only legally permissible if the formulation contains zero substances listed in Annex V of the Cosmetic Regulation and contains no multifunctional ingredients providing unlisted antimicrobial action. If hurdle technologies or non-Annex V glycols (like glyceryl caprylate) are utilized, claiming "preservative-free" is classified as misleading advertising.
How do I substantiate an "anti-aging" or "wrinkle reduction" claim in the PIF?: To display explicit efficacy claims (such as "reduces wrinkle depth by 20%"), you must archive objective evidence in Section 4 of the PIF. Acceptable proof includes randomized clinical instrumental trials (e.g., 3D skin profilometry or cutometer elasticity testing) or controlled dermatological in-use trials on human volunteers conducted by an accredited third-party testing facility.